Status:
NOT_YET_RECRUITING
A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Nicotine Dependence
Tobacco-Related Carcinoma
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigare...
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the ACT on Vaping app (Version A) and receive a text messaging program to motivate and support quitting. Participants also...
Eligibility Criteria
Inclusion
- Age 18-30
- Age of majority (to provide informed consent) in current state/territory of residence
- Current weekly user of e-cigarette product(s) for the last 30 days
- Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
- Experience downloading and using one or more apps on their smartphone
- Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app
- Has access to text messaging
- Has an email address
- United States (US) resident, with a US mailing address
- Willing to complete all study procedures
- Comfortable reading and writing in English
Exclusion
- Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation)
- Member of the same household as another research participant
- Currently in prison
- Google voice number as sole phone number, due to its association with fraudulent study entry attempts
- Is ineligible per fraud prevention protocol
- Employees/family of investigator or study center
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
1372 Patients enrolled
Trial Details
Trial ID
NCT06909500
Start Date
March 1 2026
End Date
May 1 2027
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109